October 24, 2019 - With less than 4 weeks until SMi Group’s 3rd annual Ophthalmic Drugs conference taking place on the 18th- 20th November 2019 in London, the event aims to provide great peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more.
Alongside the conference, a Pre-conference Focus Day will proceed, in which the event theme will be on ‘Novel Drug Delivery though a Complex Barrier’.
The focus day will emphasise on alternative delivery approaches to replace intravitreal drug delivery and novel drug development. Also, industry leaders will explore innovations in R&D of novel delivery methods; mechanisms including implants for IOP control; an antagonist prodrug for sustained reduction of intraocular pressure and alternatives to intravitreal delivery.
Highlights for 2020:
Safety and Efficacy of a Novel Intracapsular Drug Delivery Platform
- iVeena has developed an intracapsular drug delivery platform that enables bi-directional drug delivery to anterior and posterior eye segments
- The initial platform technology application is IVMED-20, a bioerodible dexamethasone delivery implant placed during cataract surgery to prophylax cystoid macular edema, as well as, control inflammation and pain from the procedure
Michael Burr, Vice President of Product Development, iVeena
This year’s Focus Day Chairman will be MHRA’s Medical Assessor, Peter Morgan-Warren, on ‘Regulatory perspectives on novel ocular drug delivery’ covering:
- Novel ocular drug delivery and the regulatory framework – clinical considerations
- Combination products, devices and borderline products
For the full speaker line-up, as well as the latest event details, the brochure is available
on the website.
Ophthalmic Drugs Conference
18th – 20th November 2019
Copthorne Tara Hotel, London, UK
Proudly sponsored by:
EXPERIMENTICA | ProMed Pharma
Contacts:
Sponsorship, exhibition and branding packages: Alia Malick +44 (0)20 7827 6168
Media enquiries contact Neill Howard +44 (0) 207 827 6164
Contact Information
Neill Howard
Smi Group
